Helen Susan Kim, EVP, Business Development at Kite Pharma, Inc. (KITE), sold 26,649 shares at $108.75 ($2.9M) on 2017-07-31, disclosed to the SEC on 2017-08-01.
Open-market sale of $2.9M KITE by EVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.75 | 15,804 | $1.7M | 59.0% |
| 2 | $109.74 | 7,448 | $817K | 28.1% |
| 3 | $110.55 | 2,725 | $301K | 10.3% |
| 4 | $111.60 | 672 | $75K | 2.6% |
| Total | $109.28 avg | 26,649 | $2.9M | 100% |
| Filing → |
| AMTI | SELL | 2021-08-25 | $585K | — | Filing → |
| AMTI | SELL | 2021-07-06 | $17.3M | — | Filing → |
| KITE | SELL | 2017-09-27 | $1.1M | — | Filing → |